# Vytora Health Review: NAD+, Sermorelin and Service Value | HealthspanNerds Canonical: https://healthspannerds.com/reviews/vytora-health/ Published: 2026-11-02 Updated: 2026-11-02 Evaluate Vytora’s separate wellness and weight-care subscriptions, price inconsistencies, monitoring, preparation, renewals, refunds and shipping-policy differences. [Reviews](https://healthspannerds.com/providers/)/Vytora Health Separate metabolic and wellness prescription subscriptions # Vytora Health review Vytora offers separate weight-care, NAD+ and sermorelin subscriptions. I would start by defining which service is needed, then price that agreement; the wider catalogue is not a complete preventive-health programme. NAD+ has a clear three-month total, while other plans contain monthly-label discrepancies worth settling before payment. EG[Ellis Grant](https://healthspannerds.com/authors/ellis-grant/)Consumer Editor · Updated November 2026 ## A useful next step? Consider the purpose, the care relationship and the full commitment. Visit Vytora Health↗Official provider website. No affiliate relationship is currently listed. ## A reason to consider it Readers comparing one defined remote prescription service with a confirmed preparation, monitoring arrangement and complete bill. - Current pages separately identify NAD+, sermorelin and compounded GLP-1 services. - Consultation and continuing provider messaging are described. - Selected controls state three-month charge totals. ## What deserves scrutiny Buyers seeking comprehensive preventive testing, proven healthy-lifespan gains or one price covering the entire treatment catalogue. - Monitoring and full preparation remain service-specific questions. - Several monthly figures and shipping policies conflict. - A larger catalogue does not establish preventive-care or longevity outcomes. ## Choose the service before judging the catalogue The current product pages identify NAD+ and sermorelin injections alongside compounded semaglutide and tirzepatide. They establish separate advertised services, not a package of preventive visits, comprehensive tests and all prescriptions. A coming-soon peptide section elsewhere should not erase the specific current product pages or prove additional peptides are available. [\[1\]](https://healthspannerds.com/reviews/vytora-health/#reference-1) [\[2\]](https://healthspannerds.com/reviews/vytora-health/#reference-2) [\[3\]](https://healthspannerds.com/reviews/vytora-health/#reference-3) NAD+ shows $249 monthly or $600 billed every three months. Its complete formulation, supplied quantity and shipment cadence still need confirmation. The stylized vial is expressly not the actual label or size. I would identify the assigned clinician and dispensing pharmacy before valuing a particular prescription. [\[2\]](https://healthspannerds.com/reviews/vytora-health/#reference-2) Keep a measured marker separate from a health outcome with [the biological-age testing evidence](https://healthspannerds.com/research/biological-age-tests/). ## A defined follow-up makes a price meaningful The care page describes physician messaging, a progress portal, supplies and refill delivery. It does not establish a complete included laboratory panel or scheduled preventive review. Ask which assessments and follow-up the proposed service requires, what can be booked and which costs sit outside the plan. [\[4\]](https://healthspannerds.com/reviews/vytora-health/#reference-4) Sermorelin’s panel says $199 monthly while its FAQ says $249; the selected three-month total is $559, with an approximate $186 monthly annotation. Semaglutide and tirzepatide also have monthly-label inconsistencies. Obtain the actual bill and renewal rather than add the smallest displayed figures into an imagined combined programme. [\[1\]](https://healthspannerds.com/reviews/vytora-health/#reference-1) [\[3\]](https://healthspannerds.com/reviews/vytora-health/#reference-3) [\[8\]](https://healthspannerds.com/reviews/vytora-health/#reference-8) [\[9\]](https://healthspannerds.com/reviews/vytora-health/#reference-9) Separate visits, testing and actual prescriptions in [the health-service cost planner](https://healthspannerds.com/tools/cost-planner/). ## Separate the next renewal from the current sale Product FAQs say subscriptions charge automatically until cancellation through support. They do not set a precise notice period or establish a prorated refund. Confirm the intended cancellation date and actual order stages, particularly before prepaying three months. [\[2\]](https://healthspannerds.com/reviews/vytora-health/#reference-2) [\[3\]](https://healthspannerds.com/reviews/vytora-health/#reference-3) The refund policy says all sales are final and prescription products cannot be returned for reuse or resale. Filling errors have a contact route, without an automatic refund or replacement promise. Neither that policy nor the website terms fully defines the financial result of medical nonapproval or a cancellation before preparation. Obtain those terms before submitting payment. [\[5\]](https://healthspannerds.com/reviews/vytora-health/#reference-5) [\[7\]](https://healthspannerds.com/reviews/vytora-health/#reference-7) Compare another broad catalogue and purchase agreement in [our Velvet Rx service-and-terms review](https://healthspannerds.com/reviews/velvet-rx/). Compare another recurring purchase and cancellation arrangement in [our myRocky purchase-terms review](https://healthspannerds.com/reviews/myrocky/). ## Do not turn convenience into evidence of longer healthy life Free-shipping advertising conflicts with policy language about checkout charges. The shipping policy also allows processing and transit delays. Generic warm-shipment stability statements should not replace storage and excursion advice for the actual pharmacy preparation. Service-specific terms qualify nationwide access claims too. [\[2\]](https://healthspannerds.com/reviews/vytora-health/#reference-2) [\[4\]](https://healthspannerds.com/reviews/vytora-health/#reference-4) [\[6\]](https://healthspannerds.com/reviews/vytora-health/#reference-6) [\[7\]](https://healthspannerds.com/reviews/vytora-health/#reference-7) I would compare Vytora for a defined clinical service, rather than a general longevity promise. Compounded medicines are not FDA-approved. A larger menu, convenient messages or reported energy changes do not establish improved healthy lifespan, and evidence for weight treatment cannot simply be transferred to NAD+ or sermorelin. [\[1\]](https://healthspannerds.com/reviews/vytora-health/#reference-1) [\[2\]](https://healthspannerds.com/reviews/vytora-health/#reference-2) [\[3\]](https://healthspannerds.com/reviews/vytora-health/#reference-3) [\[10\]](https://healthspannerds.com/reviews/vytora-health/#reference-10) Compare another defined preparation and follow-up arrangement in [our KIN Meds service-scope review](https://healthspannerds.com/reviews/kin-meds/). ## Understanding the cost NAD+ $249 monthly/$600 each three months. Sermorelin panel $199 monthly versus FAQ $249; selected three-month total $559. Semaglutide $179 monthly/$447 three-month total with a conflicting monthly label; tirzepatide product $249 monthly/$599 three-month total versus homepage FAQ $199 monthly. Separate services, not a combined package. [Build your cost estimate](https://healthspannerds.com/tools/cost-planner/) ## Read alongside this review [Biological-age tests: what a younger number actually establishes](https://healthspannerds.com/research/biological-age-tests/) [Home blood pressure: a useful record needs a treatment pathway](https://healthspannerds.com/research/home-blood-pressure-monitoring/) ## Sources - Vytora: catalogue and homepage pricing FAQ - Vytora: NAD+ product and selected monthly/three-month plans - Vytora: sermorelin plans and conflicting monthly FAQ - Vytora: messaging, portal and refill claims - Vytora: complete prescription refund policy - Vytora: processing, delivery and shipping charges - Vytora: platform, clinical entities and eligibility terms - Vytora: semaglutide and selected three-month billing - Vytora: tirzepatide selected plans - FDA: compounded drugs and premarket approval limits This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.